Search

Your search keyword '"Nakagawa, Masahiro"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Nakagawa, Masahiro" Remove constraint Author: "Nakagawa, Masahiro" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
50 results on '"Nakagawa, Masahiro"'

Search Results

1. MYH9-related disorder with sole presentation of end-stage kidney disease and long-term, recurrence-free living after living donor renal transplantation: a case report

3. THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer

4. Evolutionary histories of breast cancer and related clones

5. Wearable, wireless, multi-sensor device for monitoring tissue circulation after free-tissue transplantation: a multicentre clinical trial

7. Endoscopic features of oxyntic gland adenoma and gastric adenocarcinoma of the fundic gland type differ between patients with and without Helicobacter pylori infection: a retrospective observational study

8. ASO Visual Abstract: Resectability Status of Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery: Is Upfront Surgery Justified?

9. ASO Author Reflections: Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery Should be Regarded as Technically Resectable but Oncologically Borderline-Resectable

11. Prognosis after curative resection for stage IA gastric cancer in elderly patients: endoscopic submucosal dissection versus surgery

13. A prospective multicenter study of the magnifying endoscopic evaluation of the invasion depth of superficial esophageal cancers

14. Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis

15. Endoscopic resection is a suitable initial treatment strategy for oxyntic gland adenoma or gastric adenocarcinoma of the fundic gland type

16. Association Between Immune-Related Adverse Events and the Prognosis of Patients with Advanced Gastric Cancer Treated with Nivolumab

18. Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis

20. Is Additional Surgery Always Sufficient for Preventing Recurrence After Endoscopic Submucosal Dissection with Curability C-2 for Early Gastric Cancer?

21. Long-term outcomes after non-curative endoscopic submucosal dissection for early gastric cancer according to hospital volumes in Japan: a multicenter propensity-matched analysis

22. Age-related remodelling of oesophageal epithelia by mutated cancer drivers

23. Molecular pathogenesis of disease progression in MLL-rearranged AML

24. Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer? A comparative study

25. The characteristics and outcomes of small bowel adenocarcinoma: a multicentre retrospective observational study

26. Survival Benefit of Additional Surgery After Non-curative Endoscopic Submucosal Dissection for Early Gastric Cancer: A Propensity Score Matching Analysis

27. Long-term oncological outcomes of submucosal manipulation during non-curative endoscopic submucosal dissection for submucosal invasive gastric cancer: a multicenter retrospective study in Japan

29. Erratum to: Multicenter Prospective Study on the Safety of Upper Gastrointestinal Endoscopic Procedures in Antithrombotic Drug Users

31. Multicenter Prospective Study on the Safety of Upper Gastrointestinal Endoscopic Procedures in Antithrombotic Drug Users

32. Comparison of Salvage Total Pharyngolaryngectomy and Cervical Esophagectomy Between Hypopharyngeal Cancer and Cervical Esophageal Cancer

33. Risk factors for complications after pharyngolaryngectomy with total esophagectomy

34. Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastases

35. Recurrent CDC25C mutations drive malignant transformation in FPD/AML

39. Is postoperative adjuvant chemoradiotherapy necessary for high-risk oropharyngeal squamous cell carcinoma?

Catalog

Books, media, physical & digital resources